Safety evaluation of the food enzyme alpha-amylase from a genetically modified Bacillus subtilis (strain NBA)

被引:3
作者
Silano, Vittorio
Baviera, Jose Manuel Barat
Bolognesi, Claudia
Bruschweiler, Beat Johannes
Cocconcelli, Pier Sandro
Crebelli, Riccardo
Gott, David Michael
Grob, Konrad
Lampi, Evgenia
Mortensen, Alicja
Riviere, Gilles
Steffensen, Inger-Lise
Tlustos, Christina
Van Loveren, Henk
Vernis, Laurence
Zorn, Holger
Herman, Lieve
Penninks, Andre
Zeljezic, Davor
Andryszkiewicz, Magdalena
Arcella, Davide
Liu, Yi
Engel, Karl-Heinz
Chesson, Andrew
机构
关键词
food enzyme; alpha-amylase; 4-alpha-D-glucan glucanohydrolase; EC; 3.2.1.1; 1,4-alpha-D-glucan glucanohydrolase; Bacillus subtilis; genetically modified microorganism; ASPERGILLUS-DERIVED ENZYMES; ALLERGY; GLUCOAMYLASE; RESPONSES; SEQUENCE; GENOME; BREAD; GENE;
D O I
10.2903/j.efsa.2019.5681
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The food enzyme alpha-amylase (4-alpha-D-glucan glucanohydrolase; EC 3.2.1.1) is produced with a genetically modified strain of Bacillus subtilis strain NBA by DSM Food Specialities B.V. This alpha-amylase is intended to be used in baking processes. The genetic modifications do not give rise to safety concerns and the food enzyme is free from viable cells of the production organism and recombinant DNA. The parental strain meets the required qualifications to be considered as a Qualified Presumption of Safety (QPS) organism and is therefore presumed to be safe. Since the production strain is not cytotoxic and since the introduced genetic modifications do not raise safety concerns, the presumption of safety made for the parental strain is extended to the production strain. The conclusions on safety of the food enzyme are made following the QPS approach in relation to the production strain, with additional consideration of the conditions of manufacture. However, the Panelconsiders no toxicological studies other than assessment of allergenicity necessary. This is based on the QPS status of the production strain and the absence of any hazards from the product and downstream processing. Based on the maximum use level recommended for the baking processes and individual data from the European Food Safety Authority (EFSA) Comprehensive European Food Consumption Database, dietary exposure was estimated to be up to 0.093 mg TOS/kg body weight per day in European populations. The Panelconsidered that, under the intended conditions of use, the risk of allergic sensitisation and elicitation reactions upon dietary exposure to this food enzyme cannot be excluded, but the likelihood is considered low. Based on the data provided, the Panelconcluded that this food enzyme does not raise safety concerns under the intended conditions of use. (C) 2019 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.
引用
收藏
页数:15
相关论文
共 26 条
  • [1] Guidance on the risk assessment of genetically modified microorganisms and their products intended for food and feed use EFSA Panel on Genetically Modified Organisms (GMO)
    Andersson, Hans Christer
    Arpaia, Salvatore
    Bartsch, Detlef
    Casacuberta, Josep
    Davies, Howard
    du Jardin, Patrick
    Flachowsky, Gerhard
    Herman, Lieve
    Jones, Huw
    Kaerenlampi, Sirpa
    Kiss, Jozsef
    Kleter, Gijs
    Kuiper, Harry
    Messean, Antoine
    Nielsen, Kaare Magne
    Perry, Joe
    Poeting, Annette
    Sweet, Jeremy
    Tebbe, Christoph
    von Wright, Atte Johannes
    Wal, Jean-Michel
    [J]. EFSA JOURNAL, 2011, 9 (06)
  • [2] [Anonymous], EFSA J
  • [3] Guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance
    Aquilina, Gabriele
    Bories, Georges
    Chesson, Andrew
    Cocconcelli, Pier Sandro
    de Knecht, Joop
    Dierick, Noel Albert
    Gralak, Mikolaj Antoni
    Gropp, Jurgen
    Halle, Ingrid
    Hogstrand, Christer
    Leng, Lubomir
    Puente, Secundino Lopez
    Haldorsen, Anne-Katrine Lundebye
    Mantovani, Alberto
    Martelli, Giovanna
    Mezes, Miklos
    Renshaw, Derek
    Saarela, Maria
    Sejrsen, Kristen
    Westendorf, Johannes
    [J]. EFSA JOURNAL, 2012, 10 (06)
  • [4] Why can patients with baker's asthma tolerate wheat flour ingestion? Is wheat pollen allergy relevant?
    Armentia, A.
    Diaz-Perales, A.
    Castrodeza, J.
    Duenas-Laita, A.
    Palacin, A.
    Fernandez, S.
    [J]. ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2009, 37 (04) : 203 - 204
  • [5] From a consortium sequence to a unified sequence: the Bacillus subtilis 168 reference genome a decade later
    Barbe, Valerie
    Cruveiller, Stephane
    Kunst, Frank
    Lenoble, Patricia
    Meurice, Guillaume
    Sekowska, Agnieszka
    Vallenet, David
    Wang, Tingzhang
    Moszer, Ivan
    Medigue, Claudine
    Danchin, Antoine
    [J]. MICROBIOLOGY-SGM, 2009, 155 : 1758 - 1775
  • [6] Guidance on Safety assessment of botanicals and botanical preparations intended for use as ingredients in food supplements
    Barlow, Susan
    Chesson, Andrew
    Collins, John D.
    Flynn, Albert
    Galli, Corrado L.
    Hardy, Anthony
    Jany, Klaus-Dieter
    Jeger, Michael-John
    Knaap, Ada
    Kuiper, Harry
    Larsen, John-Christian
    Lovell, David
    Schlatter, Josef
    Silano, Vittorio
    Smulders, Frans
    Vannier, Philippe
    [J]. EFSA JOURNAL, 2009, 7 (09)
  • [7] ALLERGIC REACTION AFTER EATING ALPHA-AMYLASE (ASP-O-2)-CONTAINING BREAD
    BAUR, X
    CZUPPON, AB
    [J]. ALLERGY, 1995, 50 (01) : 85 - 87
  • [8] BRISMAN J, 1991, BRIT J IND MED, V48, P604
  • [9] Baker's asthma
    Brisman, J
    [J]. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2002, 59 (07) : 498 - 502
  • [10] Clinical responses to ingested fungal alpha-amylase and hemicellulase in persons sensitized to Aspergillus fumigatus?
    Cullinan, P
    Cook, A
    Jones, M
    Cannon, J
    Fitzgerald, B
    Taylor, AJN
    [J]. ALLERGY, 1997, 52 (03) : 346 - 349